FR2619718B1 - NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION - Google Patents

NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION

Info

Publication number
FR2619718B1
FR2619718B1 FR8712708A FR8712708A FR2619718B1 FR 2619718 B1 FR2619718 B1 FR 2619718B1 FR 8712708 A FR8712708 A FR 8712708A FR 8712708 A FR8712708 A FR 8712708A FR 2619718 B1 FR2619718 B1 FR 2619718B1
Authority
FR
France
Prior art keywords
impregnation
per
subdilutions
beta2
mimetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8712708A
Other languages
French (fr)
Other versions
FR2619718A1 (en
Inventor
Josiane Clairet Epouse Ayache
Jean-Jacques Ayache
Georges Bruttmann
Patrick Pedrali
Serge Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medibrevex
Original Assignee
Medibrevex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8712708A priority Critical patent/FR2619718B1/en
Application filed by Medibrevex filed Critical Medibrevex
Priority to CA000576310A priority patent/CA1328621C/en
Priority to ES88420298T priority patent/ES2087855T3/en
Priority to EP88420298A priority patent/EP0306422B1/en
Priority to JP63216431A priority patent/JP2716155B2/en
Priority to AT88420298T priority patent/ATE138565T1/en
Priority to DE3855323T priority patent/DE3855323T2/en
Publication of FR2619718A1 publication Critical patent/FR2619718A1/en
Priority to US07/587,592 priority patent/US5080903A/en
Application granted granted Critical
Publication of FR2619718B1 publication Critical patent/FR2619718B1/en
Priority to GR960402086T priority patent/GR3020722T3/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

In these new pharmaceutical dosage forms, the beta2-mimetic is contained in strictly controlled and reproducible amounts in solid vehicles contrived for a gradual release of the active principle per- and sublingually. <??>The process for preparing these new pharmaceutical dosage forms entails the following steps: - dissolution of a beta2-mimetic in a polar solvent to obtain a stock solution; - preparation of dilutions at different concentrations; - fractionation of each of these dilutions into subdilutions; - impregnation by multi-impregnation or fractional impregnation of a pharmaceutically acceptable solid vehicle with each of the subdilutions, each of the abovementioned impregnation steps being followed by a forced-air drying with moisture-free air at a temperature not exceeding 30 DEG C; - protective final impregnation of the sugar-coating type.
FR8712708A 1987-09-02 1987-09-02 NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION Expired - Fee Related FR2619718B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8712708A FR2619718B1 (en) 1987-09-02 1987-09-02 NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION
ES88420298T ES2087855T3 (en) 1987-09-02 1988-09-01 NEW GALLENIC FORMS OF BETA-2-MIMETICS FOR ADMINISTRATION BY VIA PER- AND SUBLINGUAL.
EP88420298A EP0306422B1 (en) 1987-09-02 1988-09-01 Galenical forms of 2-beta-mimetics for perlingual and sublingual administration
JP63216431A JP2716155B2 (en) 1987-09-02 1988-09-01 Beta-2-mimetetics galenic preparation and method for producing the same
CA000576310A CA1328621C (en) 1987-09-02 1988-09-01 Galenic forms of beta-2-mimetics for per- and sublingual administration
AT88420298T ATE138565T1 (en) 1987-09-02 1988-09-01 GALENIC 2-BETA MIMETIC FORMS FOR PER- AND SUBLINGUAL ADMINISTRATION
DE3855323T DE3855323T2 (en) 1987-09-02 1988-09-01 Galenic 2-beta mimetic forms for per- and sublingual administration
US07/587,592 US5080903A (en) 1987-09-02 1990-09-24 Galenical forms of beta-2-mimetics for administration perlingually and sublingually
GR960402086T GR3020722T3 (en) 1987-09-02 1996-08-05 Galenical forms of 2-beta-mimetics for perlingual and sublingual administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712708A FR2619718B1 (en) 1987-09-02 1987-09-02 NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION

Publications (2)

Publication Number Publication Date
FR2619718A1 FR2619718A1 (en) 1989-03-03
FR2619718B1 true FR2619718B1 (en) 1991-07-12

Family

ID=9354872

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8712708A Expired - Fee Related FR2619718B1 (en) 1987-09-02 1987-09-02 NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION

Country Status (9)

Country Link
US (1) US5080903A (en)
EP (1) EP0306422B1 (en)
JP (1) JP2716155B2 (en)
AT (1) ATE138565T1 (en)
CA (1) CA1328621C (en)
DE (1) DE3855323T2 (en)
ES (1) ES2087855T3 (en)
FR (1) FR2619718B1 (en)
GR (1) GR3020722T3 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
JP2909678B2 (en) * 1991-03-11 1999-06-23 レール・リキード・ソシエテ・アノニム・プール・レテュード・エ・レクスプロワタシオン・デ・プロセデ・ジョルジュ・クロード Method and apparatus for producing gaseous oxygen under pressure
FR2720276B1 (en) * 1994-05-24 1997-09-05 Christophe Boyer New therapeutic use of betamimetics agents and drug containing them.
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (en) 1995-04-20 1997-05-23 Seppic Sa THERAPEUTIC COMPOSITION COMPRISING AN ANTIGEN OR AN IN VIVO GENERATOR OF A COMPOUND COMPRISING AN AMINO ACID SEQUENCE
EP0805679A1 (en) * 1995-11-28 1997-11-12 Christophe Boyer Therapeutical use of beta-mimetic agents for the transmucosal treatment of dysmenorrhoea
WO1998018827A1 (en) * 1996-10-28 1998-05-07 Farmarc Nederland B.V. Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
WO1999040898A2 (en) * 1998-02-12 1999-08-19 Centrapharm Inc. Sublingual drug formulations having combined rapid onset of action and long lasting therapeutic effect
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8357114B2 (en) * 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US9289583B2 (en) * 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
AU2007302256A1 (en) * 2006-09-27 2008-04-03 Niconovum Ab Directional use
ES2635137T3 (en) * 2007-08-07 2017-10-02 Acelrx Pharmaceuticals, Inc. Transmucosal oral dosage forms comprising sufentanil and triazolam
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
EP2910240B1 (en) * 2014-02-25 2021-07-07 Biologische Heilmittel Heel GmbH Method for the manufacture of globules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH156609A (en) * 1931-01-27 1932-08-15 Chem Pharm Lab Bika V Poehlman Method of making a dry, homeopathic remedy.
US3975391A (en) * 1973-12-26 1976-08-17 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]ethyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US5080903A (en) 1992-01-14
CA1328621C (en) 1994-04-19
JP2716155B2 (en) 1998-02-18
ES2087855T3 (en) 1996-08-01
DE3855323D1 (en) 1996-07-04
DE3855323T2 (en) 1996-10-10
GR3020722T3 (en) 1996-11-30
EP0306422B1 (en) 1996-05-29
FR2619718A1 (en) 1989-03-03
JPH01100117A (en) 1989-04-18
EP0306422A1 (en) 1989-03-08
ATE138565T1 (en) 1996-06-15

Similar Documents

Publication Publication Date Title
FR2619718B1 (en) NOVEL GALENIC FORMS OF BETA-2-MIMETICS FOR PER- AND SUBLINGUAL ADMINISTRATION
NL300277I1 (en) Galenic forms of allergens for sublingual administration.
FR2627696B1 (en) NEW GALENIC FORM OF FENOFIBRATE
NL950007I1 (en) 1,2,4-Triazine derivatives, process for the preparation of these compounds, and pharmaceutical compositions containing these compounds.
RU92016415A (en) NEURO-PROTECTIVE DERIVATIVES OF INDOLON AND RELATED DERIVATIVES
FR2716450B1 (en) Process for the preparation of acetic acid by gentle oxidation of ethanol.
FI871087A0 (en) Process for the preparation of therapeutically active 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo / oxo-5-pyrimidinecarboxylic acid derivatives
NO912142D0 (en) FORADDITIVE FOR FISH.
NO175976C (en) Analogous Process for the Preparation of Therapeutically Active 4- (1,6-Dihydro-6-oxo-pyridazinyl-3-oxy) -3-chromanol derivatives
FR2310764A1 (en) ORAL-ADMINISTERED SOLID DRUG FORMS OF WATER-SOLUBLE XANTHINE DERIVATIVES
FR2621483B1 (en) NOVEL GALENIC FORMS OF CORTICOIDS FOR PER- AND SUBLINGUAL ADMINISTRATION AND THEIR PREPARATION PROCESS
FI900145A0 (en) Process for the Preparation of Pharmaceutically Useful 1,1-Dioxocephem-4-Carbothiol Acid Derivatives
FR2609897B1 (en) NOVEL GALENIC FORMS OF GAMMAGLOBULINS FOR PER- AND SUB-LINGUAL ADMINISTRATION
NO174962C (en) Analogous Process for Preparation of Therapeutically Active 2,5,6,7-Tetranor-4,8-Inter-m-Phenylene PGI2 Derivatives
FR2609896B1 (en) NOVEL GALENIC FORMS OF GAMMAGLOBULINS AS ANTI-INFLAMMATORY FOR PER- AND SUB-LINGUAL ADMINISTRATION
FI906084A0 (en) Process for the preparation of novel therapeutically useful 5- (2-methyl-4,4,4-trifluorobutylcarbamoyl) indole derivatives
KR890012960A (en) Crystalline β-lactam Solvate
MY101266A (en) Pharmaceutical formulations
OA03929A (en) Process for the preparation of active derivatives of indole.
OA05039A (en) Process for the preparation of active derivatives of acetic acid.
OA05756A (en) Process for the preparation of derivatives of epoxy-1,2-propylphosphonic acid.
CH429025A (en) Process for the preparation of N-methylated derivatives of basic antibiotics
NO167974C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINOPROPANOLE DERIVATIVES OF 3- (2-HYDROXYPHENYL) -1-PROPANONE COMPOUNDS.
NO175099C (en) Analogous Process for Preparation of Therapeutically Active 1,3,5-Tritian Derivatives

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 09/89

TP Transmission of property
ST Notification of lapse
GC Lien (pledge) constituted